AstraZeneca sells Crohn's disease drug for $380M
November 23, 2015 at 09:39 AM EST
AstraZeneca entered into an agreement Monday to sell the U.S rights to its Crohn’s disease Entocort to Perrigo Co...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.